[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Next-Generation Biologics Market Research Report 2016

October 2016 | 107 pages | ID: G3508CA28A1EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Next-Generation Biologics

Revenue, means the sales value of Next-Generation Biologics

This report studies Next-Generation Biologics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Allergan
  • Bayer
  • Biogen Idec
  • Eli Lilly
  • Kyowa Hakko Kirin
  • Molecular Partners
  • Novo Nordisk
  • Pfizer
  • Roche
  • Sanofi
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Next-Generation Biologics in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Antibodies
  • Regenerative medicine
  • Insulins
  • Growth hormones
  • Other
Split by application, this report focuses on consumption, market share and growth rate of Next-Generation Biologics in each application, can be divided into
  • Medical
  • Scientific Research
  • Other
Global Next-Generation Biologics Market Research Report 2016

1 NEXT-GENERATION BIOLOGICS MARKET OVERVIEW

1.1 Product Overview and Scope of Next-Generation Biologics
1.2 Next-Generation Biologics Segment by Type
  1.2.1 Global Production Market Share of Next-Generation Biologics by Type in 2015
  1.2.2 Antibodies
  1.2.3 Regenerative medicine
  1.2.4 Insulins
  1.2.5 Growth hormones
  1.2.6 Other
1.3 Next-Generation Biologics Segment by Application
  1.3.1 Next-Generation Biologics Consumption Market Share by Application in 2015
  1.3.2 Medical
  1.3.3 Scientific Research
  1.3.4 Other
1.4 Next-Generation Biologics Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Next-Generation Biologics (2011-2021)

2 GLOBAL NEXT-GENERATION BIOLOGICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Next-Generation Biologics Production and Share by Manufacturers (2015 and 2016)
2.2 Global Next-Generation Biologics Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Next-Generation Biologics Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Next-Generation Biologics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Next-Generation Biologics Market Competitive Situation and Trends
  2.5.1 Next-Generation Biologics Market Concentration Rate
  2.5.2 Next-Generation Biologics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Next-Generation Biologics Production and Market Share by Region (2011-2016)
3.2 Global Next-Generation Biologics Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL NEXT-GENERATION BIOLOGICS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Next-Generation Biologics Consumption by Regions (2011-2016)
4.2 North America Next-Generation Biologics Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Next-Generation Biologics Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Next-Generation Biologics Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Next-Generation Biologics Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Next-Generation Biologics Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Next-Generation Biologics Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL NEXT-GENERATION BIOLOGICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Next-Generation Biologics Production and Market Share by Type (2011-2016)
5.2 Global Next-Generation Biologics Revenue and Market Share by Type (2011-2016)
5.3 Global Next-Generation Biologics Price by Type (2011-2016)
5.4 Global Next-Generation Biologics Production Growth by Type (2011-2016)

6 GLOBAL NEXT-GENERATION BIOLOGICS MARKET ANALYSIS BY APPLICATION

6.1 Global Next-Generation Biologics Consumption and Market Share by Application (2011-2016)
6.2 Global Next-Generation Biologics Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NEXT-GENERATION BIOLOGICS MANUFACTURERS PROFILES/ANALYSIS

7.1 Allergan
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Next-Generation Biologics Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Allergan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Bayer
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Next-Generation Biologics Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Bayer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Biogen Idec
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Next-Generation Biologics Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Biogen Idec Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Eli Lilly
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Next-Generation Biologics Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Eli Lilly Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Kyowa Hakko Kirin
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Next-Generation Biologics Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Kyowa Hakko Kirin Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Molecular Partners
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Next-Generation Biologics Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Molecular Partners Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Next-Generation Biologics Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novo Nordisk Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Pfizer
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Next-Generation Biologics Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Pfizer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Roche
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Next-Generation Biologics Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Roche Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Sanofi
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Next-Generation Biologics Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Sanofi Next-Generation Biologics Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview

8 NEXT-GENERATION BIOLOGICS MANUFACTURING COST ANALYSIS

8.1 Next-Generation Biologics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Next-Generation Biologics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Next-Generation Biologics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NEXT-GENERATION BIOLOGICS MARKET FORECAST (2016-2021)

12.1 Global Next-Generation Biologics Production, Revenue Forecast (2016-2021)
12.2 Global Next-Generation Biologics Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Next-Generation Biologics Production Forecast by Type (2016-2021)
12.4 Global Next-Generation Biologics Consumption Forecast by Application (2016-2021)
12.5 Next-Generation Biologics Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Next-Generation Biologics
Figure Global Production Market Share of Next-Generation Biologics by Type in 2015
Figure Product Picture of Antibodies
Table Major Manufacturers of Antibodies
Figure Product Picture of Regenerative medicine
Table Major Manufacturers of Regenerative medicine
Figure Product Picture of Insulins
Table Major Manufacturers of Insulins
Figure Product Picture of Growth hormones
Table Major Manufacturers of Growth hormones
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Next-Generation Biologics Consumption Market Share by Application in 2015
Figure Medical Examples
Figure Scientific Research Examples
Figure Other Examples
Figure North America Next-Generation Biologics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Next-Generation Biologics Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Next-Generation Biologics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Next-Generation Biologics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Next-Generation Biologics Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Next-Generation Biologics Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Next-Generation Biologics Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Next-Generation Biologics Production of Key Manufacturers (2015 and 2016)
Table Global Next-Generation Biologics Production Share by Manufacturers (2015 and 2016)
Figure 2015 Next-Generation Biologics Production Share by Manufacturers
Figure 2016 Next-Generation Biologics Production Share by Manufacturers
Table Global Next-Generation Biologics Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Next-Generation Biologics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Next-Generation Biologics Revenue Share by Manufacturers
Table 2016 Global Next-Generation Biologics Revenue Share by Manufacturers
Table Global Market Next-Generation Biologics Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Next-Generation Biologics Average Price of Key Manufacturers in 2015
Table Manufacturers Next-Generation Biologics Manufacturing Base Distribution and Sales Area
Table Manufacturers Next-Generation Biologics Product Type
Figure Next-Generation Biologics Market Share of Top 3 Manufacturers
Figure Next-Generation Biologics Market Share of Top 5 Manufacturers
Table Global Next-Generation Biologics Production by Regions (2011-2016)
Figure Global Next-Generation Biologics Production and Market Share by Regions (2011-2016)
Figure Global Next-Generation Biologics Production Market Share by Regions (2011-2016)
Figure 2015 Global Next-Generation Biologics Production Market Share by Regions
Table Global Next-Generation Biologics Revenue by Regions (2011-2016)
Table Global Next-Generation Biologics Revenue Market Share by Regions (2011-2016)
Table 2015 Global Next-Generation Biologics Revenue Market Share by Regions
Table Global Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table China Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table India Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Next-Generation Biologics Consumption Market by Regions (2011-2016)
Table Global Next-Generation Biologics Consumption Market Share by Regions (2011-2016)
Figure Global Next-Generation Biologics Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Next-Generation Biologics Consumption Market Share by Regions
Table North America Next-Generation Biologics Production, Consumption, Import & Export (2011-2016)
Table Europe Next-Generation Biologics Production, Consumption, Import & Export (2011-2016)
Table China Next-Generation Biologics Production, Consumption, Import & Export (2011-2016)
Table Japan Next-Generation Biologics Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Next-Generation Biologics Production, Consumption, Import & Export (2011-2016)
Table India Next-Generation Biologics Production, Consumption, Import & Export (2011-2016)
Table Global Next-Generation Biologics Production by Type (2011-2016)
Table Global Next-Generation Biologics Production Share by Type (2011-2016)
Figure Production Market Share of Next-Generation Biologics by Type (2011-2016)
Figure 2015 Production Market Share of Next-Generation Biologics by Type
Table Global Next-Generation Biologics Revenue by Type (2011-2016)
Table Global Next-Generation Biologics Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Next-Generation Biologics by Type (2011-2016)
Figure 2015 Revenue Market Share of Next-Generation Biologics by Type
Table Global Next-Generation Biologics Price by Type (2011-2016)
Figure Global Next-Generation Biologics Production Growth by Type (2011-2016)
Table Global Next-Generation Biologics Consumption by Application (2011-2016)
Table Global Next-Generation Biologics Consumption Market Share by Application (2011-2016)
Figure Global Next-Generation Biologics Consumption Market Share by Application in 2015
Table Global Next-Generation Biologics Consumption Growth Rate by Application (2011-2016)
Figure Global Next-Generation Biologics Consumption Growth Rate by Application (2011-2016)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Next-Generation Biologics Market Share (2011-2016)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Next-Generation Biologics Market Share (2011-2016)
Table Biogen Idec Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Idec Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Idec Next-Generation Biologics Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Next-Generation Biologics Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kyowa Hakko Kirin Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Kyowa Hakko Kirin Next-Generation Biologics Market Share (2011-2016)
Table Molecular Partners Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Molecular Partners Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Molecular Partners Next-Generation Biologics Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Next-Generation Biologics Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Next-Generation Biologics Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Next-Generation Biologics Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Next-Generation Biologics Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Next-Generation Biologics Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Next-Generation Biologics
Figure Manufacturing Process Analysis of Next-Generation Biologics
Figure Next-Generation Biologics Industrial Chain Analysis
Table Raw Materials Sources of Next-Generation Biologics Major Manufacturers in 2015
Table Major Buyers of Next-Generation Biologics
Table Distributors/Traders List
Figure Global Next-Generation Biologics Production and Growth Rate Forecast (2016-2021)
Figure Global Next-Generation Biologics Revenue and Growth Rate Forecast (2016-2021)
Table Global Next-Generation Biologics Production Forecast by Regions (2016-2021)
Table Global Next-Generation Biologics Consumption Forecast by Regions (2016-2021)
Table Global Next-Generation Biologics Production Forecast by Type (2016-2021)
Table Global Next-Generation Biologics Consumption Forecast by Application (2016-2021)


More Publications